A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

NCT05755438 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Prurigo

Interventions

DRUG: Ruxolitinib Cream
DRUG: Vehicle Cream

Sponsor

Incyte Corporation